NCT04530058View on ClinicalTrials.gov

The Effects of Metformin on Morbidity and Mortality in Elderly Patients

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2029

Conditions
Burns
Interventions
DRUG

Metformin

Metformin 500 mg twice a day, administered orally or via gastric tube.

DRUG

Placebos

Placebo twice a day, administered orally or via gastric tube.

Trial Locations (1)

L8L 2X2

Hamilton Health Sciences Centre, Hamilton

All Listed Sponsors
lead

Hamilton Health Sciences Corporation

OTHER

NCT04530058 - The Effects of Metformin on Morbidity and Mortality in Elderly Patients | Biotech Hunter | Biotech Hunter